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Abstract
Aberrations of Notch signaling have been implicated in a variety of human cancers. Oncogenic
mutations in NOTCH1 are common in human T-cell leukemia and lymphomas. However, loss-of-
function somatic mutations in NOTCH1 arising in solid tumors imply a tumor suppressor
function, which highlights the need to understand Notch signaling more completely. Here we
describe the small GTPase RhoE/Rnd3 as a downstream mediator of Notch signaling in squamous
cell carcinomas (SCCs) that arise in skin epithelia. RhoE is a transcriptional target of activated
Notch1, which is attenuated broadly in SCC cells. RhoE depletion suppresses Notch1-mediated
signaling in vitro, rendering primary keratinocytes resistant to Notch1-mediated differentiation
and thereby favoring a proliferative cell fate. Mechanistic investigations indicated that RhoE
controls a key step in Notch1 signaling by mediating nuclear translocation of the activated portion
of Notch1 (N1IC) through interaction with importins. Our results define RhoE as a Notch1 target
that is essential for recruitment of N1IC to the promoters of Notch1 target genes, establishing a
regulatory feedback loop in Notch1 signaling. This molecular circuitry may inform distinct cell
fate decisions to Notch1 in epithelial tissues where carcinomas such as SCC arise.
Introduction
Squamous cell carcinomas (SCCs) are the most common cancers worldwide with more then
700 000 new cases diagnosed each year. A major regulator of squamous cell differentiation
is the Notch signaling pathway (1–3). It has been previously recognized that NOTCH1 gene
expression and activity are substantially down modulated in keratinocyte cancer cell lines
and tumors and suppression of Notch signaling in this system promotes aggressive tumor
growth (4, 5). These findings are likely of clinical significance since recent studies identified
loss-of-function mutation in NOTCH1 in squamous cell carcinomas (SCCs) (6–8). This is in
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contrast to previously described oncogenic gain-of-function aberrations in Notch in T-cell
leukemia and lymphomas suggesting that this signaling pathway may function as a tissue-
specific tumor suppressor in squamous epithelia (3). While in the majority of mammalian
systems, Notch activation is generally thought to maintain stem cell potential, promote
proliferation and inhibit differentiation (9–12), in squamous cells, increased Notch signaling
results in cell cycle arrest and initiation of a terminal differentiation program (1–3). Another
major pathway that has been linked to control of squamous cell fate determination, is that
triggered by the small GTP-ases of the Rho family (13–15). Particularly, a new member of
the small GTP-ase family of proteins, RhoE/Rnd3, was identified as a potential regulator of
keratinocyte withdrawal from the cell cycle and commitment to differentiation (16). GTP-
ases are regulatory proteins that function as molecular switches cycling between the active
GDP-bound, and inactive, GTP-bound states (17). In contrast to typical Rho family proteins,
Rnd proteins, including RhoE/Rnd3 remain in the constitutively active, GTP-bound state
without GTP hydrolytic regulation (18–21). Recently, key effectors of small Rho GTP-ases
like ROCK1/2 and MRCKa (5) were found to be transcriptional targets of the tumor
suppressor p53/Notch1 signaling in the epidermis and to counteract the Notch mediated
commitment to differentiation in keratinocytes.
Materials and Methods
Cell Culture Experiments
Primary and immortalized HKC were cultured in SFM Medium (Invitrogen). U2OS cells
and all SCC cell lines were grown in DMEM supplemented with 10% bovine serum.
Quantitative real time RT PCR, chromatin immunoprecipitation and immunodetection
techniques
The list of relevant antibodies is provided in the Supplemental Information. Conditions for
real time and conventional PCR analysis, chromatin immunoprecipitation ChIP,
immunoblotting and immunofluorescence were as previously described (5). Significant
increase or decrease of mRNA levels or %bound Chromatin throughout the experiments was
considered when p< 0.05.
RhoE loxp/loxp mice
Mutant mice were generated at inGenious Targeting Laboratory, USA (detailed strategy for
generating the animals is described in the Supplemental Information).
The genotyping PCR primers for the RhoE-loxp mutant allele were as follows:
P1-F : TGCTGGTGGTGAAATTCAAGTCGC
P2-R: ACTCCAGTCATTCCAAGTCTCCCT
Promoter activity assays
RhoE-luc, Hey2-luc, HES1-AB-luc, HES1-ΔAB-luc, and CSL-responsive luciferase reporter
constructs were previously described (2, 5, 22).
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In vitro differentiation assay
Primary human keratinocytes were brought into suspension and plated on Petri dishes coated
with poly-HEMA (10 mg/ml in ethanol, Sigma). At indicated time-points cells were
collected by centrifugation and processed for total RNA preparation (RNeasy, Qiagen).
In vivo cysts formation assays
For in vivo cyst formation assays, control and RhoE siRNA transfected cells were brought
into suspension and injected (1.5×106 cells/injection) intradermaly in 8 weeks old female
athymic nude mice. Seven days later animals were sacrificed and formed cysts were excised
and frozen in OCT. Sections were analyzed by H&E staining and immunolabeling with a
Keratin 5 and Keratin 10 antibody.
Results
RhoE/RND3 and Notch1 levels correlate in human squamous cell carcinoma
Since exome sequencing data of oral and skin SCCs did not identify mutations in RhoE (6–
8) we sought to determine its expression pattern in patient derived SCC samples as well as
SCC cell lines. We observed down-modulated Notch1 expression levels, lower levels of
activated Notch1 and decreased RhoE expression in SCC samples as compared to controls
(Fig. 1A and B). A similar analysis of a panel of patient-derived oral or skin SCC samples
and normal controls (32 total number of samples) showed a significant suppression of RhoE
expression in the SCC samples as compared to the matched controls (Fig. 1C and
Supplementary Fig. S1).
RhoE is a direct transcriptional target gene of Notch signaling in squamous epithelium
To investigate the possibility that RhoE is a downstream effector of Notch signaling in
squamous epithelial cells, we checked its expression in primary human keratinocytes (HKC)
infected with an adenovirus expressing activated form of Notch1 (AdN1IC) and detected a
significant induction of RhoE mRNA and protein levels upon ectopic expression of
activated Notch1 (N1IC) (Fig. 2A). This effect was specific for RhoE only, since other
members of the same family of proteins remained unchanged under similar condition
(Supplementary Fig. S2A, B). In addition, Notch1 seems to be a specific activator of RhoE
expression in keratinocytes since down modulation of Notch2 was not sufficient to modulate
RhoE levels (Supplementary Fig. S2C). Alternatively, to mimic endogenous activation of
Notch1 by ligand interaction with neighboring cells, HKC were co-cultured for 48 hrs with
NIH3T3 fibroblasts expressing the full-length Jagged 1 ligand (2, 23). Real-time RT-PCR
analysis with human-specific primers showed that RhoE mRNA was increased significantly
(Fig. 2B) correlating to increased mRNA levels of the Notch target gene Hey2
(Supplementary Fig. S3). Conversely, to assess the effects of suppression of endogenous
Notch signaling in HKC on RhoE expression, we relied on two complementary approaches.
Treatment with γ-secretase inhibitors, for example DAPT, blocks activation of endogenous
Notch receptors (24, 25), whereas retroviral mediated expression of a 51-amino-acid peptide
corresponding to the amino-terminus of the MAML1 protein (MAM51) provides an
effective method to suppress canonical Notch/CSL/MAML-dependent transcription (26).
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Both conditions resulted in suppression of RhoE mRNA (Fig. 2C left panel, D) and protein
levels (Fig. 2E). To determine whether de novo protein synthesis is required for suppression
of the RhoE expression by DAPT, human primary keratinocytes were pre-treated with the
protein synthesis inhibitor cycloheximide for 2 hrs and RhoE levels in the presence or
absence of DAPT were assessed by real time RT-PCR. We observed a decrease of RhoE
mRNA expression in the presence of DAPT. When cycloheximide treatment was applied
after DAPT wash-out, RhoE mRNA expression returned to control levels (Fig. 2C, right
panel). We next investigated whether RhoE expression is under Notch control also in the
mouse epidermis both in vitro and in vivo. Primary mouse keratinocytes from mice with the
Notch1 gene flanked by loxP (Notch1loxp/loxp) sites were infected with a Cre-expressing
adenovirus (AdCre) for deletion of the Notch1 gene. Efficient loss of Notch1 expression
upon infection with AdCre was confirmed by immunoblot analysis with an anti-Notch1
antibody (Fig. 2F). Relative to parallel cultures infected with a control GFP-expressing
adenovirus (AdGFP), keratinocytes with deletion of the Notch1 gene exhibited a
significantly decreased RhoE mRNA (Fig. 2F). In vivo, conditional keratinocyte specific
deletion of the Notch1 gene in the epidermis upon crossing of the Notch1loxp/loxp mice with
mice expressing the Cre recombinase from the Keratin 14 promoter, also resulted in
markedly decreased RhoE mRNA levels (Fig. 2G).
We next hypothesized that RhoE acts as a direct Notch1/CSL transcriptional target. To
determine if Notch1 transcriptional complex occupies genomic segments of the RhoE
promoter in vivo we used chromatin immunoprecipitation (ChIP) scanning assay and
surveyed ~4kb of genomic DNA upstream of the transcription starting site (TSS) of human
RhoE. The scanning ChIP was performed in primary HKC after IP with an antibody against
the endogenous N1IC and real-time PCR was used for chromatin binding quantification. We
detected a significant enrichment of Notch1 containing complex in the −1kB region of the
RhoE promoter (Fig. 3A). Nucleotide sequence analysis of the human RhoE promoter
revealed the presence of a consensus CSL binding site at ~0.4kB upstream of the TSS.
Quantitative ChIP assay by real time PCR using primers targeting the −0.4kB region
containing the CSL binding site revealed a significant amplification of this genomic
fragment. Importantly, binding od activated Notch1 to the RhoE promoter was abrogated
upon DAPT treatment (Fig. 3B, left panel). Cotransfection of an N1IC expression plasmid
with a luciferase-linked RhoE promoter construct containing around 2kb of the genomic
region upstream of the RhoE TSS into SCC028 cells resulted in an increased luciferase
activity, whereas co-transfection with vector alone failed to do so (Fig. 3C). We next
generated a deletion mutation in the −0.4 kb CSL-binding (Fig. 3D). The mutated promoter
significantly decreased luciferase activity in response to activated Notch1 when compared to
the wild type RhoE promoter (Fig. 3D). These results demonstrate that RhoE is a
transcriptional target of Notch1 and that the −0.4 kb CSL-binding site plays a role in Notch-
mediated RhoE transcription.
RhoE potentiates Notch1 activity in SCC cells and normal keratinocytes in vitro and in vivo
Next we examined the biological significance of RhoE for downstream Notch signaling in
SCC cells and observed a suppression of Notch target genes expression upon depletion of
RhoE levels with two unique siRNA oligonucleotides (Fig. 4A, B; Supplementary Fig.
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4SA). While the effects of RhoE depletion for the SCC cells were not very striking, they
were comparable in magnitude with pharmacological inhibition of Notch signaling using
DAPT (Supplementary Fig. S4B). In order to explore the effects of a complete suppression
of RhoE on Notch1 signaling, we used primary mouse keratinocytes derived from mutant
animals, where the first 2 exons of the RhoE gene are surrounded by loxP sites and
transduced them with control AdGFP or AdCre constructs. In agreement with our previous
findings, we were able to show that lack of functional RhoE in the mouse epidermis results
in decrease of mRNA levels of the Notch target gene Hes1 (Fig. 4C). Notably, the
expression of other Rho family members was not affected upon RhoE depletion
(Supplementary Fig. S5A, B). These results suggest that RhoE is not only a new direct target
of Notch1, but RhoE may be required for the ability of Notch to induce its downstream
targets. To further address this question, we transfected primary HKC with RhoE siRNA and
subsequently infected them with AdN1IC or control AdGFP. Real time RT-PCR analysis
showed that the basal levels of Notch1 targets Hey2 and Hes1 were reduced by RhoE
knockdown (Fig. 4D). In order to avoid off-target effects of the siRNA, a second RhoE
siRNA was used for transfection (Supplementary Fig. S4C). Moreover, the induction of
these transcripts by activated Notch1 was also blocked in the RhoE siRNA transfected cells
(Fig. 4D). Similar results were obtained for Hes1 protein levels after immunoblot analysis
(Fig. 4E). In addition, silencing RhoE expression in SCC028 cells resulted in a significant
suppression of Notch1 target Hey2 promoter activity when compared to cells transfected
with a control siRNA (Fig. 4F). Applying identical conditions, we observed inhibition of
luciferase activity from a reporter construct carrying the promoter of another Notch1 target
gene, Hes1 (Hes1-AB). The specificity of the assay was tested with a mutated Hes1
promoter construct devoid of CSL-binding sites in its sequence (Hes1-ΔAB-luc), which
didn’t respond to RhoE depletion (Fig. 4F).
Because activated Notch1 is a key inducer of growth arrest and commitment to
differentiation in both SCC cells and normal HKC (1, 2, 27) and RhoE was previously
implicated in control of HKC differentiation (16), we depleted RhoE using siRNA in SCC
cells and looked at their differentiation profile. We observed a down-modulation of the
differentiation marker Keratin 1 (Fig. 5A and Supplementary Fig. S5A with a second
independent RhoE siRNA). To dissect the effect of RhoE on the differentiation program of
squamous epithelium and ask the question if it is part of a disrupted Notch signaling in the
system, we used primary HKC and looked at the “suspension” model of Notch-mediated
kerarinocyte differentiation induced upon loss of attachment to the surface (5, 28). We
observed a strong increase of RhoE expression upon keratinocytes differentiation mirroring
the expression level of Keratin 1 (Supplementary Fig. S6A, B). When RhoE expression was
knocked-down by siRNA approach, the suspension conditions failed to induce Keratin 1
expression (Fig. 5B). In agreement with these findings, overexpression of N1IC was not able
to induce expression levels of Keratin1 and Involucrin in keratinocytes with RhoE depletion
(Fig. 5C, D).
We next determined the relevance of RhoE in this context in vivo. Primary HKC transfected
with control or RhoE siRNA were injected into immunodeficient nude mice at the dermal-
epidermal junction, i.e. a location allowing the formation of multilayer cysts closely
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resembling the differentiation profile of the normal epidermis. In control mice, as expected,
the injected cells gave rise to cornified epithelial cysts with well distinguishable keratinocyte
layers starting from a proliferating basal layer and finishing with one or two cornified layers
(Fig. 5E, left panel). However, RhoE siRNA transfected keratinocytes formed lesions with a
significantly expanded basal proliferating layer and missing cornified envelope (Fig. 5E,
right panel). The knock-down of RhoE in the cysts was confirmed by real time RT-PCR as
well as Western blot (Supplementary Fig. S7B) and the effect of RhoE knock-down on cyst
formation was reproduced using a second RhoE siRNA (Supplementary Fig. S7C).
Immunofluorescence analysis of these cysts further confirmed the expansion of the basal
layer of keratinocytes as showed by the increase of Keratin 5 and decrease of Keratin 10
expression in the RhoE siRNA transfected cells versus control (Fig. 5F). Therefore, our
results strongly suggest that RhoE counteracts the “basal cell-like” phenotype in the
epidermis, and suppression of RhoE expression results in an increased proliferation and the
failure to commit to differentiation in keratinocytes both in vitro and in vivo.
RhoE binds to Notch1 and mediates its translocation to the nucleus
Our findings suggest that RhoE and Notch1 are linked by a molecular circuitry, whereby
activated Notch1 signaling increases the transcription of RhoE, while suppression of RhoE
levels abbrogates downstream Notch1 signaling. Given the trafficking function of several
other small GTP-ases (29–32), we hypothesized that RhoE may influence Notch1 transport
into the nucleus. Indeed, in U2OS osteosarcoma cells stably expressing Flag-RhoE and
infected with AdN1IC, N1IC was found in a complex with RhoE upon reciprocal
immunoprecipitation and Western blot (Fig. 6A). The interaction in vivo was additionally
confirmed by reciprocal immunoprecipitaion of endogenous N1IC or RhoE followed by
Western blotting for endogenous RhoE or N1IC respectively in SCC4 cells (Fig. 6A). GST-
pull down assay using recombinant N1IC (aa1758-aa2556)-GST fusion protein and Western
blot for endogenous RhoE confirmed the direct nature of this interaction (Fig. 6B). These
biochemical results are consistent with the immunofluorescence results, in which co-
localization of endogenous N1IC and RhoE in the cytoplasm and the nucleus was detected
in SCC4 cells (Fig. 6C) by confocal microscopy. The specificity of the labeling was tested
on the same cells using only secondary antibodies and double labeling of cells treated with
DAPT or RhoE siRNA (Supplementary Fig. 8A-C). In addition the co-localization of RhoE
and Notch1 in SCC4 cells was visualized using a Duolink assay for RhoE/Notch1
interaction in situ. In this assay the secondary antibodies are conjugated to oligonucleotides
that comprise one-half of a closed circle that can be ligated together only when the
antibodies are in close proximity (<40 nm) (Fig. 6D). Next we addressed the question of
how the activated portion of Notch1 translocates to the nucleus. Since Notch1 contains a
classical nuclear localization signal (33), its nuclear import might depend on the association
with transport receptors of the importin α and β family (reviewed in (34)). Indeed, the
interaction between activated Notch1 and importin α / β1 was revealed in extracts from
SCC4 cells, immunoprecipitated with an anti N1IC antibody and analyzed by Western blot
for importin α / β1 (Fig. 6E). Importantly, this N1IC/ importin β1interaction required the
presence of RhoE since we observed a decrease of N1IC binding to importin β1 when RhoE
expression was down-modulated (Fig. 6F). Similar findings were obtained using a second
set of RhoE siRNA oligos (Supplementary Fig. 9A, B).
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RhoE is essential for recruitment of activated Notch1 to its target gene promoters in SCC
cells
We next hypothesized that by mediating the translocation of N1IC to the nucleus, RhoE
regulates the ability of N1IC to affect transcription of its target genes. First, we investigated
the binding of NICD to the Hes1 promoter after infection with V5 tagged AdN1IC in
primary HKC previously transfected with control siRNA versus cells with RhoE siRNA.
Knock-down of RhoE expression inhibited the binding of activated Notch1 to the CSL
binding site of the Hes1 promoter as assessed by quantitative ChIP/real-time PCR analysis
using a primer pair able to amplify the CSL-binding site of the human Hes1 promoter (Fig.
7A right panel). Similarly, when immortalized HKC were forced to differentiate, ChIP using
an antibody against endogenous N1IC detected decrease of binding upon depletion of RhoE
expression (Fig. 7A right panel). To assess whether this is reflection of a block of
cytoplasmic-nuclear translocation of the N1IC, we transfected SCC4 cells with RhoE or
control siRNA. RhoE down-modulation (using two different sets of RNAi oligos) prevented
accumulation of activated Notch1 in the nuclear fraction of the cells (Fig. 7B). To further
confirm the defect of Notch1 nuclear translocation upon RhoE depletion, we developed a
co-culture system in which U2OS cells stably expressing full length Notch1 with a GFP tag
at the intracellular part were transfected with control or RhoE siRNA and 24 hrs later seeded
on NIH3T3 cells expressing a control or Jagged2 plasmid to initiate ligand dependent
cleavage of the GFP-Notch1 construct. Down-modulation of RhoE expression by siRNA
prevented the translocation of intracellular Notch to the nucleus (Fig. 7C). Importantly, the
block in N1IC nuclear translocation upon RhoE depletion was comparable to the effect of
DAPT in the same cells (Fig. 7D). Together, theses data suggest that RhoE is essential for
the transduction of downstream Notch signaling in keratinocytes and the binding of
activated Notch1 on the promoter regions of its direct target genes.
Discussion
We describe here a novel role for RhoE in the control of Notch mediated differentiation of
SCC cells. RhoE expression is suppressed in human SCCs and down-modulation of RhoE
levels leads to suppressed differentiation potential. Our results demonstrate that RhoE is a
novel Notch1 effector, which is essential for binding of activated Notch to its downstream
targets and ability to modulate the differentiation program in SCC cells. Recently, it became
evident that loss-of-function mutations in NOTCH1 are very frequent in skin and oral SCCs
(6–8). These studies also demonstrated that aberrations in Notch signaling in SCCs are
important for tumor progression rather than initiation and predict that loss-of-function of the
Notch pathway serves as a second “hit” to allow cells with “initiating” oncogenic mutations
to progress and develop into tumors. In this context, the role of Notch as a major driver of
squamous differentiation becomes critical since the key feature of squamous neoplasia of all
types is disrupted commitment to differentiation. Interestingly, the majority of the identified
NOTCH1 mutations in SCCs are heterozygous. This observation suggests that although loss
of a single copy is probably sufficient to functionally decrease Notch activity, the remaining
level of intact signaling may be essential to prevent excessive growth, as SCCs, specifically
those in the skin, are known for lack of aggressiveness and slow progression. Hence,
downstream effectors of the Notch pathway involved in the differentiation program of
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squamous cells become essential for controlling growth of SCC cells. From our data, it
appears that depletion of RhoE in SCC cells causes inappropriate differentiation phenotype
probably through altered Notch downstream signaling. While several studies described
earlier how ligand binding activates Notch function through the proteolytically mediated
generation of an active intracellular domain of Notch (35), the direct translocation of the
intracellular domain to the nucleus remains elusive. Here we identify RhoE as an essential
player in this process. RhoE enables the binding of NICD to importin β1 and thus ensures
the proper translocation of NICD to the nucleus. We argue that the Notch1 target RhoE may
influence Notch regulation through a positive feed-back loop, which regulates the
translocation of the activated form of Notch to the nucleus. Alterations in this mode of
action may result in growth-related disorders such as cancer. It was reported that RhoE
expression is reduced in some cancer cells (36, 37) and this is linked to its anti-proliferative
function (38) given the fact that RhoE function, due to its lack of GTPase activity, is
primarily regulated on transcriptional level. Our finding that in human squamous cell
carcinomas, down-modulation of Notch1 expression correlates with deregulated expression
of RhoE, underscores the relevance of these observations for the development and growth of
keratinocyte derived cancers. As recently reported, Notch signaling in HKC doesn’t have a
general growth inhibitory effect, but it rather inhibits the expansion of “stem cell” like
populations partially through inhibition of ROCK1/2 and MRCKa expression (5). Since
RhoE functions as an inhibitor of ROCK signaling in various cell types, the inhibition of the
expansion of “stem cell” like population by Notch signaling in SCC cells may be mediated
through Notch1→RhoE pathway.
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Figure 1. RhoE expression is down-regulated in SCC cell lines and tumors in parallel with
Notch1 levels
A, Primary HKC were analyzed in parallel with SCC cell lines (SCCO28, Cal27 and FaDu)
by real time RT-PCR for Notch1 and RhoE mRNA levels using 36B4 as internal control. B,
The same set of cells as in A, were analyzed for protein levels of Notch1 and RhoE using β-
actin as a loading control. In addition protein levels of the cleaved part of Notch1 were
detected with Val1744 specific antibody (lower panel). C, Total RNA from 23 surgically
excised oral SCC subjected to laser dissection microscopy (as in (5) were analyzed along
with normal epithelium for RhoE mRNA expression by real time RT-PCR using 36B4 as
control. The results are expressed as fold changes of RhoE expression in the tumors versus
normal epithelium. Error bars represent Standard Deviations, calculated based on triplicate
values.
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Figure 2. RhoE expression is regulated by Notch1 in keratinocytes
A, Notch activation induces RhoE expression. HKC were infected with AdN1IC or control
AdGFP, followed by assessment of RhoE mRNA levels by real time RT-PCR (left panel)
and protein levels after Western blot. B, HKC were co-cultured with control mouse NIH
3T3 fibroblasts or NIH 3T3 fibroblasts stably expressing full-length Jagged1 for 48 hours,
followed by real-time RT-PCR analysis of RhoE mRNA levels. C, HKC were treated with
10 μM DAPT or DMSO vehicle control for 24 hrs, after that DAPT was washed out with
PBS and cell culture medium and cells were treated with cycloheximide for 2. RhoE mRNA
levels were then assessed by real time RT-PCR analysis. D, MAM51-mediated inhibition of
Notch transcription suppresses RhoE expression. (E) Western blot analysis of RhoE protein
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levels in MAM51 overexpressing or DAPT treated primary HKC with tubulin as a loading
control. F, Primary mouse keratinocytes from homozygous Notchloxp/loxp were infected with
AdCre or AdGFP control. At 72 hours after infection, cells were analyzed either by real time
RT-PCR analysis and immunoblotting for RhoE expression levels using 36B4 mRNA levels
or γ-tubulin protein levels for normalization, respectively. The deletion of the Notch1 gene
was confirmed by immunoblotting with a Notch specific antibody. G, Real time RT-PCR
analysis was used to analyze RhoE mRNA levels, using mouse GAPDH for internal
normalization. Relative mRNA levels are presented as a fold change as compared to the
control condition. Error bars represent Standard Deviations, calculated based on three
independent measurements.
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Figure 3. Identification of RhoE as a transcriptional target of Notch1
A, Endogenous Notch1 is enriched at −1kb genomic region from the transcription start site
(TSS) of human RhoE. Primary HKC were forced to differentiate in suspension and
processed for scanning ChIP of the −5kb genomic region upstream of the human RhoE TSS,
as described in the Supplementary Information, using an antibody against the activated form
of Notch1 or purified rabbit IgGs. B, Differentiated primary HKC, teraetd with DMSO
control or DAPT were processed for ChIP as in (A) followed by real time PCR analysis
(upper panel) or conventional PCR (lower pane) using specific primers (described in
Supplementary Information) to amplify the −0.4kb region of the human RhoE promoter
containing the CSL binding site. Efficiency of the immunoprecipitation is shown in the right
panel: Western blot analysis of immunoprecipitates performed either with non-specific IgG
or with the antibody against the activated form of Notch1. C, SCC028 cells were transfected
with a N1IC construct or empty vector together with the RhoE reporter (RhoE-luc) and
phRL-TK Renilla reporter. D, The promoter regions were analyzed using the rVista software
for identification of transcription factor binding sites. The CSL binding site at position −0.4
kb was deleted, and SCC028 keratinocyte cells were transfected with the mutated or with the
wild type luciferase reporter constructs together with the NICD construct and phRL-TK
Renilla reporter. Error bars represent Standard Deviations, calculated based on three
independent measurements.
Zhu et al. Page 14
Cancer Res. Author manuscript; available in PMC 2015 April 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4. Depletion of RhoE inhibits downstream Notch signaling
A, SCC4, SCC13 and SCC15 cancer cell lines were transfected with control and RhoE
siRNA and the levels of the Notch target genes Hey2 and HES1 were analyzed by real time
RT-PCR analysis using 36B4 as an internal control. B, Protein levels of Hey2, HES1 and
RhoE in the same cells were analyzed by Western blot using actin levels as an internal
loading control. C, Inducible keratinocyte-specific deletion of the RhoE gene and resulting
effects on Notch signaling and keratinocyte differentiation. Left upper panel: Schematic
representation of the murine RhoE gene and of the expected recombination products leading
to its inducible tissue-specific deletion. After induction of Cre recombinase activity (the
loxP sites are indicated with red arrows), the genomic portion harboring the first two exons
are deleted. Left lower panel: PCR analysis of genomic DNA of offspring from the RhoE
loxp/loxp homozygous mice: the primers amplify a larger fragment including the loxp site
and wild type genomic DNA is presented as a control. Middle panel: Real-time RT-PCR
analysis of mRNA isolated from primary keratinocytes derived from mutant RhoE loxp/loxp
mice and infected with an adenovirus expressing the Cre recombinase or an Ad-GFP
control. At 2 days after infection levels of Hes1 are decreased in cells with Cre activity upon
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calcium mediated induction of differentiation. Depletion of RhoE mRNA levels shown on
the right. D, Primary HKC under growing adherent conditions were transfected with control
(scrambled siRNA) or RhoE siRNA, and 48 hours later were infected with adenoviruses
expressing either GFP (AdGFP) or the activated form of Notch1 (AdN1IC). 24 hours later
expression of Notch1 target genes, Hey2 and HES1 was analyzed by real time RT-PCR. E,
RhoE and HES1 expression in the same cells was analyzed by Western blot. F, SCC028
cells transfected with control or RhoE siRNA were transfected with luciferase reporters for
Hey2 (Hey2-luc, 0.5mg), wild type HES1 containing both CSL binding sites in the promoter
region (HES1-AB-luc, 0.5mg) or HES1-ΔAB-luc with mutated CSL binding sites together
with a Renilla minimal reporter (0.05 mg) for internal normalization. 24 hrs after
transfection, luciferase activity was measured and normalized with Renilla activity. Error
bars represent Standard Deviations, calculated based on three independent measurements.
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Figure 5. RhoE ablation suppresses growth and commitment to differentiation in vitro and
enhances the proliferative phenotype in vivo
A, SCC4, SCC13 and SCC15 cells were depleted of RhoE expression using siRNA and
Keratin 1 mRNA was analyzed 48 hrs later using real time RT-PCR. B, Primary HKC
transfected with control or RhoE siRNA were kept under growing conditions (time point 0)
or induced to differentiate by suspension or the indicated times. Keratin1 mRNA levels were
analyzed by real time RT-PCR. C, Knockdown of RhoE inhibits the Notch1-mediated
induction of Keratin 1 and Involucrin. Primary HKC under growing adherent conditions
were transfected with control or two different RhoE siRNAs, and 48 hours later infected
with adenoviruses AdGFP or AdN1IC. 24 hours later commitment of keratinocytes to
differentiation was analyzed by Keratin 1 or Involucrin mRNA levels. D, HKC transfected
with control or RhoE siRNA were treated as in C, and analyzed for RhoE, Keratin 1 and
Involucrin protein levels by Western blot using tubulin as a loading control. E, Human HKC
transfected with control or RhoE siRNA were injected into immunodeficient nude mice at
the dermal-epidermal junction. To minimize individual animal variations, the same mice
were injected in parallel with control siRNA transfected keratinocytes. 7 days later cysts
were harvested, and tissues were processed. F, The same cysts from above experiments were
stained with a Keratin 5 specific antibody (green staining in the right panel). Shown are
multilayer cysts with well-differentiated keratinocytes building a cornified envelope in the
control samples and a large “basal” layer of proliferating keratinocytes with increased
Keratin 5 expression (green staining) and decreased Keratin 10 expression (red staining) in
the RhoE siRNA tissues. Nuclei were stained in blue (Hoechst staining). Error bars represent
Standard Deviations, calculated based on three independent measurements.
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Figure 6. RhoE binds to N1IC and promotes its importin β1-mediated nuclear import
A, Coimmunoprecipitation of N1IC by RhoE. Cellular extracts from U2OS cells stably
expressing Flag-tagged RhoE and infected with AdN1IC were immunoprecipitated using
Flag antibody followed by Western blotting for N1CD and RhoE. Endogenous association
between N1IC and RhoE in SCC4 cells was analyzed be coimunoprecipitation of N1IC or
RhoE followed by Western blot for the indicated proteins. B, GST-pull down assay was also
performed: RhoE binds to recombinant N1IC fused to GST but not to GST alone. C, N1IC
and RhoE colocalize in the cytoplasm and the nucleus of SCC4 cells by
immunofluorescence staining using antibodies for endogenous RhoE and N1IC. The images
were then analyzed by confocal microscopy. D, Representative images of SCC4 cell with
Duolink fluorescence (red spots) generated by the interaction of the anti RhoE and anti
N1IC antibodies (DAPI was used to stain the nucleus). Negative control images were
generated by omitting the RhoE antibody. E, N1IC interacts with Importin family members.
Cellular lysates of SCC4 cells were tested for the endogenous association between N1IC and
importin β1 or α by immunoprecipitation with anti N1IC versus control IgG followed by
Western blotting for importin α and β1. F. Depletion of RhoE abrogates the binding
between NIIC and importin β1. SCC4 cells were transfected with either scrambled or RhoE
siRNA and 48 hours later subjected to immunoprecipitation with an anti N1IC antibody
followed by Western blotting using anti importin β1 and Notch1 antibodies. Rabbit IgG was
used as a control (left panel). The decrease of immunoprecipitaed importin β1 was measured
using UNISCANIT software. RhoE knock-down was measured by immunoblotting (right
panel).
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Figure 7. RhoE promotes N1IC transcriptional activity and importin β1-mediated nuclear
import
A, RhoE knock-down inhibits Notch1-induced CSL-transcription in normal keratinocytes.
Human primary keratinocytes under growing conditions were transfected with control
siRNA, or RhoE siRNA followed by infection with an adenoviral construct encoding the
activated form of Notch1 with a V5 C-terminal tag. 24 hours later cells were processed for
ChIP with V5 specific antibodies or non-immune IgG control followed by PCR
amplification of the CSL/Notch binding site-containing region of the human HES1 promoter
(left panel). Differentiated primary HKC were processed for ChIP as in Figure 3 using
endogenous N1IC for immunoprecipitation (right panel). The results from the ChIP assay
were quantified by real time PCR analysis. Error bars represent Standard Deviations,
calculated based on three independent measurements. B, RhoE inhibition prevents
accumulation of activated Notch1 in the nucleus. Primary HKC transfected with RhoE
siRNA were induced to differentiate by suspension culture, followed by nuclear and
cytoplasmic fractionation and immunoblot analysis for the full length and activated Notch1
proteins using H3 and GAPDH as loading controls for the nuclear and cytosolic fractions,
respectively. RhoE knockdown was assessed by Western blot analysis as shown in the right
panel. C, U2OS cells stably expressing the full length Notch1-GFP (the GFP tag is at the
intracellular end of the protein) transfected with control or RhoE siRNA and seeded over
NIH3T3 cells expressing control empty vector or full length Jagged2 were analyzed for
ligand mediated translocation of cleaved Notch1-GFP to the nucleus 24hrs later by
fluorescent microscopy. D, Same co-culture system as in C but imaging was performed on
live cells and the effects of RhoE siRNA were compared to DAPT treatment.
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